Cheng Yu Tsai

Dr. Cheng Yu Tsai


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2024 in Biomolecules & Therapeutics
Verified
Journal Article
Open access
PDF file
SLSher-Wei Lim
Sher-Wei Lim
WCWei-Chung Chen
Wei-Chung Chen
HKHuey-Jiun Ko
Huey-Jiun Ko
YSYu-Feng Su
Yu-Feng Su
CWChieh-Hsin Wu
Chieh-Hsin Wu
CTCheng Yu Tsai
Cheng Yu Tsai
Sher-Wei Lim, Wei-Chung Chen, Huey-Jiun Ko, Yu-Feng Su, Chieh-Hsin Wu, Fu-Long Huang, Chien-Feng Li and Cheng Yu Tsai. Biomolecules & Therapeutics 2025;33:129-42. https://doi.org/10.4062/biomolther.2024.084

28 May 2025 in International Immunopharmacology
Verified
Journal Article
Closed access
YLYao-Lin Lee
Yao-Lin Lee
JLJoon-Khim Loh
Joon-Khim Loh
HKHuey-Jiun Ko
Huey-Jiun Ko
WCWei-Chung Chen
Wei-Chung Chen
YSYu-Feng Su
Yu-Feng Su
CTCheng Yu Tsai
Cheng Yu Tsai

27 February 2026 in Anticancer Research
Verified
Journal Article
Closed access
YSYu-Feng Su
Yu-Feng Su
HKHuey-Jiun Ko
Huey-Jiun Ko
WCWei-Chung Chen
Wei-Chung Chen
FHFu-Long Huang
Fu-Long Huang
JLJoon-Khim Loh
Joon-Khim Loh
CTCheng Yu Tsai
Cheng Yu Tsai
Glioblastoma (GBM) cells that adapt to the in vivo microenvironment often display enhanced invasion driven by EGFR-ERK signaling and epithelial-mesenchymal transition (EMT). This study aimed to characterize an EGFR-ERK-dependent T98G subline (T98G-xeno) and to determine how gallic acid (GA) modulates reactive oxygen species (ROS), EGFR-ERK signaling, EMT and migration. Parental T98G and T98G-xeno cells were compared for proliferation, EMT markers and migration. GA cytotoxicity, ROS, EGFR-ERK signaling and migration were assessed after GA, EGF, N-acetyl-L-cysteine (NAC) or EGFR siRNA treatment. T98G-xeno cells showed faster growth, increased migration, higher levels of mesenchymal markers, and elevated basal p-EGFR/p-ERK ratio versus T98G cells. Non-apoptotic GA increased ROS, decreased p-EGFR/EGFR and p-ERK/ERK ratios, restored E-cadherin/ZO-1, reduced N-cadherin/vimentin and inhibited wound closure and migration. EGF-induced EGFR-ERK activation and migration were antagonized by GA. EGFR siRNA mimicked GA, whereas NAC attenuated GA-induced ROS and partially rescued these effects. GA targets a ROS-EGFR-ERK-EMT axis in T98G-xeno cells, acting as a non-cytotoxic modulator that reverses EMT and limits migration. These findings suggest that GA-based strategies may help restrain invasion in EGFR-ERK-addicted, EMT-enriched GBM.

18 September 2024 in Medicina
Verified
Journal Article
Open access
PDF file
CTCheng Yu Tsai
Cheng Yu Tsai
KKKeng-Liang Kuo
Keng-Liang Kuo
CWChieh-Hsin Wu
Chieh-Hsin Wu
TTTai-Hsin Tsai
Tai-Hsin Tsai
HSHui Yuan Su
Hui Yuan Su
JLJoon-Khim Loh
Joon-Khim Loh
Background and Objectives: Pediatric traumatic brain injury (pTBI) remains a major pediatric public health problem, despite well-developed injury prevention programs. The purpose of this study is to analyze the emergency surgical outcomes of pTBI in a single institute ten-year retrospective study to offer a real-world clinical result. Materials and Methods: Our institute presented a clinical retrospective, single-institute research study of 150 pediatric TBI cases that were diagnosed and underwent emergency surgical treatment from 2010 to 2019. Results: The incidence of radiological findings is detailed as follows: brain edema (30%, 45/150), followed by acute subdural hematoma (27.3%, 41/150), epidural hematoma (21.3%, 32/150), chronic subdural hemorrhage (10%, 15/150), skull fracture (6.7%, 10/150), and traumatic subarachnoid hemorrhage (4.7%, 7/150). Surgical intervention data revealed that decompressive craniectomy was still the main effective surgical method. The results showed longer hospital stays and higher morbidity rates in the brain edema, acute subdural hematoma, and chronic subdural hemorrhage groups, which were viewed as poor surgical outcome groups. Epidural hematoma, skull fracture and traumatic subarachnoid hemorrhage were categorized into good surgical outcome groups. Notably, the data revealed gross improvement in Glasgow Coma Scale/Score (GCS) evolution after surgical interventions, and the time to cranioplasty was a significant factor in the development of post-traumatic hydrocephalus (PTH). Conclusions: Our study provided real-world data for the distribution of etiology in pTBI and also categorized it into six groups, indicating disease-orientated treatment. In addition, our data supported that decompressive craniectomy (DC) remains a mainstay surgical treatment in pTBI and early cranioplasty could decrease the incidence of PTH.